VitaNova Life Sciences Corporation Financials
VNOV
All currency values in $ millions unless otherwise noted
Scroll
| Income Statement | TTM | APR 2026 | APR 2025 ~2.4:1 split | APR 2024 ~1.8:1 split | APR 2023 | APR 2022 |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | $3 | $3 | $3 | $1 | $0 | $0 |
| Cost of Revenue | $2 | $2 | $1 | $0 | $0 | – |
| Gross Profit | $1 | $1 | $2 | $0 | $0 | – |
| Operating Expenses | ||||||
| Selling & Marketing | – | $0 | $0 | $0 | $0 | – |
| General & Administrative | $1 | $1 | $0 | $0 | $0 | $0 |
| Provision for Doubtful Accounts | – | $0 | $0 | – | – | – |
| Total Operating Expenses | $1 | $1 | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | $0 | $1 | $0 | -$0 | -$0 |
| Non-Operating | ||||||
| Net Interest Expense | – | $0 | -$0 | $0 | – | – |
| Other Non-Operating Income (Expense) | – | $0 | $0 | $0 | $0 | – |
| EBT (Earnings Before Tax) | – | $0 | $1 | $0 | -$0 | $0 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | ||||||
| Net Income | -$0 | -$0 | $1 | $0 | -$0 | $0 |
| Per Share Data | ||||||
| Revenue Per Share | $0.39 | $0.36 | $0.32 | $0.16 | $0.02 | $0.06 |
| EPS (Basic) | -$0.00 | -$0.00 | $0.10 | $0.03 | $0.00 | $0.06 |
| EPS (Diluted) | -$0.02 | -$0.00 | $0.09 | $0.03 | $0.00 | $0.06 |
| Weighted Avg Shares (Basic) | 8.3M | 8.3M | 25.0M | 10.6M | 5.9M | 5.9M |
| Weighted Avg Shares (Diluted) | – | – | 25.0M | 10.6M | 5.9M | 5.9M |
| Shares Outstanding | 8.3M | 8.3M | 8.3M | 3.5M | 2.0M | 2.0M |
VitaNova Life Sciences (VNOV) financials: revenue, profit and margins
VitaNova Life Sciences (VNOV) generated about $3 million in revenue and -$114,104.00 in net income (a -3.5% net margin) over the trailing twelve months, growing at roughly 124.1% a year. Figures are from SEC filings; this is analysis, not investment advice.
Frequently asked
What is VitaNova Life Sciences's (VNOV) revenue?+
VitaNova Life Sciences generated about $3 million in revenue over the trailing twelve months. Revenue has grown at roughly 124.1% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.
Is VitaNova Life Sciences profitable?+
VitaNova Life Sciences reported about -$114,104.00 in net loss over the trailing twelve months, a net margin of roughly -3.5%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
What are VitaNova Life Sciences's profit margins?+
VitaNova Life Sciences runs a gross margin of about 26.9%, an operating margin of about -2.7%, a net margin of about -3.5%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.
How fast is VitaNova Life Sciences growing?+
VitaNova Life Sciences's revenue has compounded at roughly 124.1% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside VNOV's margins and free cash flow. This is analysis from SEC filings, not investment advice.
SourceFinancial statements computed from the 10-Q filed 14 Sept 2026, covering the period ending 31 Jul 2026, as reported to the SEC. Data last refreshed 26 Sept 2026. How this is calculated.
Fiscal year ends Apr.
Peers
Wholesale-Apparel, Piece Goods & Notions · Pick stocks to compare with VNOV
Spot a number that looks wrong? Check it in VNOV's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing VNOV
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.